Clinical Overview For Attorneys
Clinical Overview For Attorneys
Clinical Overview For Attorneys
Understanding the Medical Reality of Concussion After Motor Vehicle Accidents
Motor vehicle collisions frequently result in concussion and mild traumatic brain injury (mTBI), even in the absence of direct head impact or loss of consciousness. These injuries are often underdiagnosed, undertreated, and misunderstood, leading to prolonged symptoms and disputed claims.
Rocky Mountain Concussion (RMC) was built specifically to address these gaps through objective evaluation, biologically informed treatment, and clear medical documentation that reflects the true nature of concussion injury.
Concussion Is a Physiological Brain Injury — Not a “Soft” Diagnosis
A concussion initiates a neurometabolic cascade involving:
Ionic flux and excitotoxicity
Impaired glucose metabolism
Mitochondrial dysfunction
Reduced cerebral blood flow
Neuroinflammation and oxidative stress
These changes create an energy crisis within the brain, leaving neural tissue vulnerable and functionally impaired. Importantly, this physiological disruption can persist well beyond initial symptom resolution.
This is why many patients appear “normal” on imaging yet continue to experience disabling cognitive, vestibular, visual, and autonomic symptoms.

Lack of Loss of Consciousness Does Not Mean Lack of Injury
More than 90% of concussions occur without loss of consciousness.
Similarly, low-speed collisions and rear-end impacts are fully capable of producing concussive injury through rapid acceleration–deceleration forces.
In auto accidents, concussion frequently occurs alongside:
Whiplash and cervical spine injury
Vestibular system disruption
Visual and oculomotor dysfunction
Autonomic nervous system dysregulation
Treating only neck pain or headache without addressing the brain injury itself often results in incomplete recovery.
Symptom Resolution ≠ Neurological Recovery
A critical issue highlighted in concussion research — and frequently overlooked in standard care — is that symptoms may improve while neurological dysfunction persists.
Patients may report:
Ongoing cognitive fog
Reduced processing speed
Emotional lability
Exercise intolerance
Sleep disruption
Without targeted intervention, these deficits can become chronic, forming the basis of persistent post-concussion symptoms.

RMC’s Comprehensive Clinical Approach
Rocky Mountain Concussion provides a brain-first, multidisciplinary model designed specifically for auto-accident injuries.
1. Objective, Brain-Focused Evaluation
RMC performs detailed assessments that examine:
Cognitive and neurological function
Vestibular and visual integration
Cervical involvement
Autonomic regulation
Functional tolerance to exertion
These findings form the basis for both clinical care and defensible medical documentation.
2. Biologically Targeted Neuro-Therapeutics
RMC incorporates evidence-informed peptide and neuro-supportive therapies to address the biological injury underlying concussion.
These may include:
Cerebrolysin – neurotrophic support and synaptic repair
Thymosin Beta-4 – cellular repair, angiogenesis, inflammation modulation
BPC-157 – vascular integrity, neuroinflammatory support, tissue healing
Intranasal peptides such as Semax, Selank, and RG3 for central nervous system access
Neuro-supportive supplements including NAD, NeuroMag, Creatine, and others
These therapies are medically prescribed, monitored, and integrated into the overall treatment plan — not used in isolation.
3. Specialized Rehabilitation, Addressing Systems
Affected by Concussion
RMC coordinates targeted rehabilitation for:
Vestibular dysfunction (balance, dizziness, spatial orientation)
Oculomotor and visual processing deficits
Cervical spine involvement
Autonomic nervous system regulation
Cognitive-motor integration
This approach addresses the functional manifestations of brain injury, not just symptom complaints.
4. Virtual & In-Home Care Improves Compliance & Outcomes
RMC offers virtual monitoring and in-home services, which:
Increase treatment adherence
Reduce missed appointments
Support patients with transportation or symptom limitations
Maintain continuity of care during recovery
Improved compliance directly supports measurable clinical progress and clearer medical timelines.
Clear, Attorney-Ready Documentation
Rocky Mountain Concussion provides:
Objective testing and progress tracking
Detailed medical records outlining mechanism of injury and clinical findings
Ongoing documentation of recovery trajectory
Support for insurance and legal review when required
This documentation reflects the true scope and complexity of concussion injury, helping align medical reality with case evaluation.
Why This Matters for Auto-Accident Claims
When concussion is treated as a transient complaint rather than a biological injury, patients are often discharged prematurely and left with unresolved deficits.
RMC’s model:
Identifies injury that standard care may miss
Provides medically appropriate treatment
Documents recovery accurately over time
This benefits both patient outcomes and case integrity.
A Clinical Resource for the Legal Community
Rocky Mountain Concussion serves as a specialized medical partner for attorneys handling motor vehicle accident cases involving concussion or mild traumatic brain injury.
Our focus remains on:
Proper medical care
Accurate diagnosis
Ethical documentation
Supporting true neurological recovery
For Providers and Attorneys
For questions regarding clinical protocols, referral pathways, or collaborative care, we invite you to contact our team or explore the provider-specific resources available throughout this site.
Selected Research & Evidence Base
Rocky Mountain Concussion’s clinical approach is grounded in a growing body of neuroscience and concussion research demonstrating that concussion is a metabolic and physiological brain injury, not simply a transient symptom condition.
Neurometabolic Cascade & Energy Crisis
Research has shown that concussion disrupts cellular energy production, cerebral blood flow, and mitochondrial function, creating a prolonged neurometabolic vulnerability:
Giza CC, Hovda DA. The neurometabolic cascade of concussion.
Journal of Athletic Training, 2001.Foundational paper describing ionic flux, excitotoxicity, impaired glucose metabolism, and mitochondrial dysfunction following concussion.
Giza CC, Hovda DA. The pathophysiology of traumatic brain injury.
Neurosurgery, 2014.Expanded understanding of prolonged metabolic disruption and impaired cerebral energy balance after mild TBI.
Cerebral Blood Flow & Autonomic Dysfunction
Multiple studies demonstrate persistent reductions in cerebral blood flow and autonomic dysregulation after concussion, even when symptoms appear to improve:
Len TK et al. Alterations in cerebral blood flow after sports concussion.
Journal of Cerebral Blood Flow & Metabolism, 2011.La Fountaine MF et al. Autonomic nervous system dysfunction following mild traumatic brain injury.
Brain Injury, 2011.
Symptom Resolution ≠ Neurological Recovery
Evidence shows that neurological recovery often lags behind symptom resolution, underscoring the risk of premature discharge based on symptoms alone:
McCrea M et al. Acute effects and recovery time following concussion in collegiate athletes.
JAMA, 2003.Slobounov S et al. Residual brain dysfunction observed one year post-mild traumatic brain injury.
NeuroImage, 2010.
Active Rehabilitation & Targeted Recovery
Modern concussion research supports guided, progressive rehabilitation rather than prolonged rest alone:
Leddy JJ et al. Rehabilitation of concussion and post-concussion syndrome.
Sports Health, 2012.Schneider KJ et al. Cervicovestibular rehabilitation in sport-related concussion.
British Journal of Sports Medicine, 2014.
Peptides, Neuroinflammation & Neural Repair (Emerging Evidence)
While still an evolving field, peer-reviewed research supports the role of specific peptides and peptide analogs in neurological repair, inflammation modulation, and neuroprotection:
Thon N et al. Cerebrolysin in patients with traumatic brain injury.
CNS Drugs, 2012.Demonstrated neurotrophic and neuroprotective effects supporting functional recovery.
Dash PK et al. Neuroprotective peptides and traumatic brain injury.
Peptides, 2009.Zaninotto AL et al. Neuroplasticity and recovery after traumatic brain injury.
NeuroRehabilitation, 2010.
These findings support the rationale for biologically targeted therapies that address inflammation, cellular energy, and neuroplasticity as part of a comprehensive concussion recovery strategy.
Important Note on Clinical Application
Peptide-based therapies are incorporated as evidence-informed, medically guided tools and are integrated with rehabilitation, monitoring, and individualized care. Ongoing research continues to refine best practices in this rapidly advancing area of neurotherapeutics.



